Patient characteristics and cardiovascular and mortality outcomes in patients with type 2 diabetes mellitus initiating treatment with sodium-glucose co-transporter-2 inhibitors and other antidiabetic medications in Finland

Documents

Study protocol

Initial protocol

CVD REAL FINLAND Non Interventional Study Protocol v1.0 FINAL-v4_signed

Study results

Study report

Other information

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

Signed checklist for study protocols

ER-9565_ENCePPChecklistforStudyProtocols_Protocol version 1_ 20180504_signed